Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Metastatic Triple-Negative Breast Cancer (TNBC), HR+/HER2- Breast Cancer, and locally advanced or metastatic Urothelial Carcinoma.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Targeted treatment of solid tumors and hematologic malignancies.
Prevention and treatment of chemotherapy-induced febrile neutropenia and hematopoietic recovery.
Targeted treatment of solid tumors and hematologic malignancies.
Targeted treatment of solid tumors and hematologic malignancies.
Approved for use in oncology care according to FDA-approved indications.